Atevirdine Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

CompletedTreatment1 IdentifierTitleDrugs
NCT00000742A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
NCT00000753A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC